RandyW Posted January 10, 2007 Share Posted January 10, 2007 Medical Marketing to get US patent for anti-cancer vaccine technology LONDON (AFX) - Medical Marketing International Group PLC said the US Patent and Trademark Office is to grant it a patent for the group's anti-cancer technology, following payment of standard fees. The new patent covers the use of a novel genetic adjuvant that has been shown to enhance the anti-cancer activity of DNA vaccines, the company said. This technology was granted a European patent in June 2006. MMI's DNA vaccine technologies are already in clinical trials covering around 75 pct of the most serious cancers, including lung, colon and prostate, and the first clinical trials for infectious diseases are expected in 2007. Chairman David Best said 'DNA vaccines have the potential to address major diseases in major global markets. This new patent protects a critical technical enhancement that makes DNA vaccines more effective and therefore, increases considerably the commercial value of our technology and the potential return to investors.' newsdesk@afxnews.com slm Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.